Véronique M. André mostly deals with Neuroscience, Glutamate receptor, Huntington's disease, Striatum and Cerebral cortex. Her studies in Neuroscience integrate themes in fields like AMPA receptor and Huntingtin. Her work carried out in the field of Huntingtin brings together such families of science as Dopamine and Neurodegeneration.
Her research on Glutamate receptor frequently links to adjacent areas such as NMDA receptor. The study incorporates disciplines such as Long-term potentiation and Activity-dependent plasticity in addition to Striatum. Her research investigates the connection between Epileptogenesis and topics such as Neurogenesis that intersect with issues in Pathology, Electrophysiology, Cortical dysplasia and Epilepsy.
Neuroscience, Cortical dysplasia, Electrophysiology, Epilepsy and Glutamate receptor are her primary areas of study. Her Neuroscience research is multidisciplinary, incorporating elements of Huntington's disease and Neurotransmission. Her work on Huntingtin as part of general Huntington's disease study is frequently connected to Genetically modified mouse, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Her Cortical dysplasia research integrates issues from GABAergic, Dysplasia, Pathology and Interneuron. Her Epilepsy research focuses on Hippocampus and how it connects with Status epilepticus. Her research integrates issues of NMDA receptor, Dopamine receptor D2, Indirect pathway of movement and Direct pathway of movement in her study of Glutamate receptor.
The scientist’s investigation covers issues in Neuroscience, Glutamate receptor, Pharmacology, Electrophysiology and Allosteric modulator. Her study ties her expertise on Neurotransmission together with the subject of Neuroscience. Her Glutamate receptor research is multidisciplinary, incorporating perspectives in Glioma, Huntington's disease, Function and Pathology.
She interconnects In vitro, Biophysics, Potassium channel, Anticonvulsant and Hippocampal formation in the investigation of issues within Electrophysiology. The concepts of her Allosteric modulator study are interwoven with issues in Dopaminergic, Dopamine receptor D2 and D1-like receptor. Her NMDA receptor research incorporates elements of Purinergic receptor, Patch clamp and Electroencephalography.
The scientist’s investigation covers issues in Pharmacology, Carbamazepine, Cell, SV2A and Brivaracetam. Her biological study spans a wide range of topics, including Glutamate receptor, Receptor and NMDA receptor. A majority of her Carbamazepine research is a blend of other scientific areas, such as Sodium current and Voltage-gated ion channel.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice
Michelle Gray;Dyna I. Shirasaki;Carlos Cepeda;Véronique M. André.
The Journal of Neuroscience (2008)
Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience.
Jason T. Lerner;Noriko Salamon;Jason S. Hauptman;Tonicarlo R. Velasco.
Epilepsia (2009)
The corticostriatal pathway in Huntington's disease
Carlos Cepeda;Nanping Wu;Véronique M. André;Damian M. Cummings.
Progress in Neurobiology (2007)
Pathophysiology of Huntington’s Disease: Time-Dependent Alterations in Synaptic and Receptor Function
Lynn A. Raymond;Véronique M. André;Carlos Cepeda;Clare M. Gladding.
Neuroscience (2011)
Alterations of hippocampal GABAergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy
Véronique André;Christian Marescaux;Astrid Nehlig;Jean Marc Fritschy.
Hippocampus (2001)
Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis
Carlos Cepeda;Carlos Cepeda;Véronique M. André;Véronique M. André;Michael S. Levine;Michael S. Levine;Noriko Salamon;Noriko Salamon.
Epilepsy & Behavior (2006)
Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia
Carlos Cepeda;Raymond S. Hurst;Jorge Flores-Hernández;Elizabeth Hernández-Echeagaray.
Journal of Neuroscience Research (2003)
Differential electrophysiological properties of dopamine D1 and D2 receptor‐containing striatal medium‐sized spiny neurons
Carlos Cepeda;Véronique M. André;Irene Yamazaki;Nanping Wu.
European Journal of Neuroscience (2008)
Dopamine and Glutamate in Huntington's Disease: A Balancing Act
Véronique M. André;Carlos Cepeda;Michael S. Levine.
CNS Neuroscience & Therapeutics (2010)
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease
Prasad R. Joshi;Nan Ping Wu;Véronique M. André;Damian M. Cummings.
The Journal of Neuroscience (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Princeton University
University of California, Los Angeles
University of California, Los Angeles
Inserm : Institut national de la santé et de la recherche médicale
Grenoble Alpes University
Southeast University
Jinan University
University of California, Irvine
Universidade de São Paulo
University of California, Los Angeles
Google (United States)
Zhejiang University
Google (United States)
Auburn University
Wayne State University
Eindhoven University of Technology
Australian Institute of Marine Science
Kiel University
Rigshospitalet
University of Nebraska Medical Center
Ghent University
Uppsala University
University of Florence
Stanford University
Shanghai Jiao Tong University
University of Toronto